SBIO
ALPS Medical Breakthroughs ETF
SBIO
37,70
0,12 Bil. AUM
0,5% Expense Ratio
36,63 NAV
ALPS Medical Breakthroughs ETF Profile
About ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
- Company
- ALPS Funds
- Holdings
- 97
- CUSIP
- 00162Q593
ALPS Medical Breakthroughs ETF Sectors
| Industry | Percentage |
|---|---|
| Healthcare | 95,84% |
| Other | 4,16% |